Lutey Lori A.
Known title: DirectorCIK: 0001699873
Associated companies
Transaction History
| MYE | ▲ Buy | Grant | 5,135 | $0 | 5/8/2026 | View on chart |
| MYE | ▲ Buy | Grant | 6,250 | $0 | 5/5/2025 | View on chart |
| MYE | ▲ Buy | Open Market | 1,000 | $12K | 12/5/2024 | View on chart |
| MYE | ▲ Buy | Grant | 4,534 | $0 | 5/9/2024 | View on chart |
| MYE | ▲ Buy | Grant | 5,294 | $0 | 4/27/2023 | View on chart |
| MYE | ▲ Buy | Open Market | 1,000 | $21K | 3/8/2023 | View on chart |
| MYE | ▲ Buy | Grant | 4,110 | $0 | 4/28/2022 | View on chart |
| MYE | ▲ Buy | Open Market | 500 | $9K | 3/16/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Myers Industries Sets Date for Q3 2026 Earnings Call
Myers Industries has announced the reporting date and conference call for its third-quarter 2026 results. This upcoming event will provide investors with the latest financial updates for the company. The other recent news items listed pertain to different pharmaceutical companies and are not directly related to Myers Industries.
Myers Industries Sets Date for Q3 2026 Earnings Call. Myers Industries has announced the reporting date and conference call for its third-quarter 2026 results. This upcoming event will provide investors with the latest financial updates for the company. The other recent news items listed pertain to different pharmaceutical companies and are not directly related to Myers Industries.